High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

NCT00936936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Testicular Cancer

Interventions

DRUG: Gemcitabine
DRUG: Docetaxel
DRUG: Melphalan
DRUG: Carboplatin
DRUG: Mesna
DRUG: Ifosfamide
DRUG: Etoposide
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center